Journal of Clinical Lipidology
Publisher: Elsevier · ISSN 1933-2874 · 88 articles
- Genetic determinants of chylomicronemia in Taiwan: Predominance of LPL rare variants and APOA5 p.G185C
- Lipoprotein(a) as a Biomarker in the Acute Myocardial Infarction Setting
- Diet quality, PCSK9 inhibitor use, and plasma lipids among adults with heterozygous familial hypercholesterolemia: a cross-sectional study.
- Oral PCSK9 Inhibition in the Injectable Era: Repositioning Intensive LDL-Cholesterol Lowering in Contemporary Cardiovascular Prevention
- Dyslipidemia as a Risk Factor for Pregnancy Loss: A Systematic Review
- Predicting genetically defined familial hypercholesterolemia with the FAMCAT algorithm in an Australian tertiary clinic
- Utility of clinical scoring systems, laboratory, and genetic testing for appropriate classification of patients with severe hypertriglyceridemia in a Latin American cohort
- TUDOR, an ascertainment-aware model for LDLR genetic-testing triage in specialist lipid clinics: Development, validation, and UK Biobank transport
- Reply to the Letter to the Editor: “Interpreting TyG Performance in Adolescent Prediabetes: Does the Diagnostic Definition Matter?”
- Paediatric Sitosterolemia With Two Novel ABCG8 Variants of Uncertain Significance in Trans
- Beyond sitosterol: A multivariable sterol model improves diagnosis of pediatric sitosterolemia in the gray zone
- Efficacy and safety of inclisiran monotherapy in Chinese adults with elevated low-density lipoprotein cholesterol: Results from the VICTORION-Mono China trial
- Real-world assessment of adherence to inclisiran dosing schedule and LDL-C reduction in patients with hypercholesterolemia in Austria
- Effectiveness, safety, and treatment persistence of bempedoic acid in a Spanish real-world cohort
- Evaluating elevated lipoprotein(a) clinical care impact in an academic health center
- Association of lipoprotein(a) with renal and cardiac outcomes in chronic kidney disease: a nationwide cohort study
- Lipoprotein(a) and atrial fibrillation: Meta-analysis of observational and mendelian randomization studies shows no clinically meaningful association
- Lipoprotein(a) and aortic diseases: Epidemiological evidence from observation to causation
- Association between lipoprotein (a) levels and cardiac allograft vasculopathy among heart transplant recipients: Insights from a single-center cohort
- Distribution of lipoprotein(a) and its association with atherosclerotic cardiovascular disease in a large real-world Polish cohort
- Apolipoprotein B-low-density lipoprotein cholesterol discordance refines cardiovascular risk stratification across metabolic phenotypes
- Prevalence and clinical characteristics of probable familial chylomicronaemia syndrome at a tertiary care center in Pakistan: Insights from a hospital-based screening study
- The integrated triglyceride-glucose index and body shape indices for improvements in myocardial infarction risk prediction: Findings from the Tehran Lipid and Glucose Study
- Signal vs noise when examining discordance between LDL-cholesterol and apolipoprotein-B
- Interpreting TyG performance in adolescent prediabetes: Does the diagnostic definition matter?
- Mortality, cardiovascular, and hepatic decompensation outcomes of bempedoic acid in patients with cirrhosis: A multi-institutional study
- Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations
- Incidental steatotic liver in young patients with ischemic stroke: A marker of high vascular burden and underrecognized prevention opportunity
- Discordance between remnant cholesterol and small dense LDL cholesterol obscures interpretation of the results of the PROMINENT trial
- Impact of PREVENT-ASCVD vs pooled cohort equations on statin eligibility across demographic groups: Insights from the NIH All of Us Research Program